Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
Latest reported GOSS revenue for 2026-06-30 was $26.2M. Net income was -$29.8M. Revenue was up 54.5% from 2026-03-31 to 2026-06-30. GOSS currently screens at market cap $47.0M.
Use this GOSS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the GOSS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the GOSS SEC filings page. Lician reads the product cache first so this HTML stays unique to Gossamer Bio Inc even when a live quote feed is slow.
Latest cached year on this hub. Full GOSS income, balance, and cash tables.